BioForce Nanosciences (BFNH) Short Interest Ratio & Short Volume

Short interest is the volume of BioForce Nanosciences shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 500 shares of BFNH short. 0.00% of BioForce Nanosciences' shares are currently sold short. Learn More on BioForce Nanosciences' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.00% of BioForce Nanosciences' floating shares are currently sold short.

0.00% of BioForce Nanosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to BioForce Nanosciences: Akoya Biosciences, Inc. (11.53%), Optex Systems Holdings, Inc (0.29%), Syntec Optics Holdings, Inc. (0.09%), Know Labs, Inc. (3.05%), Singular Genomics Systems, Inc. (2.91%), Autoscope Technologies Co. (0.00%), ClearSign Technologies Co. (0.53%), International Isotopes Inc. (0.00%), Data I/O Co. (0.20%), MultiSensor AI Holdings, Inc. (2.15%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($29.20 billion), Strategy Incorporated ($10.88 billion), iShares 20+ Year Treasury Bond ETF ($10.04 billion), Capital One Financial Co. ($5.51 billion), Charter Communications, Inc. ($5.00 billion), Super Micro Computer, Inc. ($4.43 billion), Apollo Global Management, Inc. ($4.02 billion), Hims & Hers Health, Inc. ($3.65 billion), VanEck Semiconductor ETF ($3.27 billion), and Coinbase Global, Inc. ($3.10 billion). View all of the most shorted stocks.

Short selling BFNH is an investing strategy that aims to generate trading profit from BioForce Nanosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for BioForce Nanosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BFNH, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BFNH, twice per month. The most recent reporting period available is May, 15 2025.